BioCentury
ARTICLE | Clinical News

Megabios regulatory update

November 16, 1998 8:00 AM UTC

Megabios Corp. (MBIO), Burlingame, Calif. Business: Gene/Cell therapy MBIO received U.S. Patent No. 5,830,878 covering a cationic lipid:DNA formulation for intravenous gene delivery and for direct in...